Serum calprotectin (S100A8/A9) levels as a new potential biomarker of treatment response in Hodgkin lymphoma.

Şeyma ŞumnuÖzgür MehtapSinan MersinTayfur ToptaşGözde GörürAyfer GedükSerkan ÜnalMerve Gökçen PolatKemal AygünEmel Merve YenihayatHayrunnisa AlbayrakMeral Uluköylü MengüçPınar TarkunAbdullah Hacıhanifioğlu

Published in: International journal of laboratory hematology (2021)

S100A8/A9 may be a potential biomarker for treatment response in HL independent of inflammation. This is the first study to investigate and show this finding. However, further large-scale studies are still required.

Keyphrases

hodgkin lymphoma
oxidative stress
rheumatoid arthritis
case control